drug · antibody
paridiprubart
Phase 3updated 6mo agoby $EDSA Edesa Biotech, Inc.🔗 ChEMBL
Phase 3community read0 votes
Antibody drug with a maximum clinical stage of Phase 2 3 (across all indications), with 5 investigational indications.
all catalysts(0)
nothing on the calendar yet
Trials studying paridiprubart
News(1)
- Kyorin pens $140M deal for Japan rights to Edesa’s phase 3 respiratory drugKyorin Pharmaceutical is paying $12 million upfront for the Japan rights to Edesa Biotech’s anti-TLR4 antibody to treat acute respiratory distress syndrome.fiercebiotech · 10d ago
Data sources
last refreshed 6h ago
Found something off?
comments(0)
5-min edit window · permanent after that